


Cadenza Bio
Biotechnology Research • United States • 1-10 Employees
Company overview
| Headquarters | United States |
| Website | |
| NAICS | 541714 |
| Founded | 2022 |
| Employees | 1-10 |
| Socials |
Key Contact at Cadenza Bio
Jamie Boney-Montoya
Director, Research & Development
Cadenza Bio Email Formats
Cadenza Bio uses 1 email format. The most common is {first name} (e.g., john@cadenza.bio), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@cadenza.bio | 100% |
About Cadenza Bio
Cadenza Bio, Inc. was founded in 2022 to accelerate and support the development of a series of novel, non-steroidal, highly selective compounds targeting Estrogen Receptor β (ERβ). Our patented and patent-pending compounds have shown therapeutic efficacy in preclinical animal models of Multiple Sclerosis and Endometriosis. Our goal goes beyond incremental improvements. We are dedicated to breaking the cycle of disease and, in doing so, transforming lives. We aim not only to alleviate symptoms but to halt progression, promote repair, and restore quality of life to enable total activity, empowering patients to regain control over their health.
Cadenza Bio revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | $4,800,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Explore Cadenza Bio's funding history, including investment rounds, total capital raised, and key backers.
Cadenza Bio Tech Stack
Discover the technologies and tools that power Cadenza Bio's digital infrastructure, from frameworks to analytics platforms.
Font scripts
JavaScript libraries
JavaScript libraries
Security
Ecommerce
JavaScript libraries
JavaScript frameworks
Security
Miscellaneous
JavaScript libraries
Ecommerce
Frequently asked questions
4.8
40,000 users



